Answers are grounded in this paper and cite their sources.
Scoping review and cohort study compare liver transplant outcomes from MAiD, DCD, and DBD donors, suggesting safety for MAiD use.
BACKGROUND: Liver transplantation from donors following medical assistance in dying (MAiD) is a novel practice with emerging Canadian outcomes data. We sought to compare donor and recipient outcomes after liver transplantation following donor MAiD, circulatory death (DCD), or brain death (DBD). METHODS: We conducted a scoping review and a single-centre retrospective cohort study. CONCLUSION: Liver transplantation from donors who underwent MAiD was not associated with higher graft loss or mortality than in those who underwent DCD or DBD. Its continued use is safe, and larger multicentre studies are warranted for validation.
No takes yet. Share an insight, caveat, or question.
Ganescu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: